G. Guéguen

620 total citations
6 papers, 403 citations indexed

About

G. Guéguen is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, G. Guéguen has authored 6 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Hematology and 1 paper in Genetics. Recurrent topics in G. Guéguen's work include Sphingolipid Metabolism and Signaling (3 papers), Platelet Disorders and Treatments (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). G. Guéguen is often cited by papers focused on Sphingolipid Metabolism and Signaling (3 papers), Platelet Disorders and Treatments (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). G. Guéguen collaborates with scholars based in France and United Kingdom. G. Guéguen's co-authors include Hugues Chap, Marie‐Françoise Simon, Frédérique Gaits‐Iacovoni, Jean‐Pierre Salles, Olivier Fourcade, Gérard Mauco, Josette Fauvel, Ama Gassama‐Diagne, Jean Plouët and Sylvie Fournel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemistry.

In The Last Decade

G. Guéguen

6 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Guéguen France 5 232 166 58 54 53 6 403
Tsukasa Ohno Japan 11 154 0.7× 50 0.3× 165 2.8× 88 1.6× 18 0.3× 17 398
Meenu Maan United Arab Emirates 7 177 0.8× 47 0.3× 79 1.4× 11 0.2× 38 0.7× 10 367
Monique Bedin France 10 188 0.8× 47 0.3× 47 0.8× 33 0.6× 6 0.1× 28 377
Yongrui Du China 9 133 0.6× 85 0.5× 94 1.6× 52 1.0× 5 0.1× 16 354
Thippeswamy Gulappa United States 10 211 0.9× 57 0.3× 35 0.6× 45 0.8× 9 0.2× 14 324
Klaudia Klicka Poland 9 165 0.7× 58 0.3× 74 1.3× 61 1.1× 4 0.1× 11 324
Arfa Mehmood Finland 9 211 0.9× 37 0.2× 42 0.7× 13 0.2× 12 0.2× 17 358
Atia A. Hamid Japan 8 230 1.0× 68 0.4× 118 2.0× 87 1.6× 2 0.0× 11 384
Meiyi Tang United States 12 160 0.7× 193 1.2× 123 2.1× 57 1.1× 2 0.0× 17 430
Payman Hanifi‐Moghaddam Netherlands 12 168 0.7× 115 0.7× 131 2.3× 26 0.5× 5 0.1× 18 406

Countries citing papers authored by G. Guéguen

Since Specialization
Citations

This map shows the geographic impact of G. Guéguen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Guéguen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Guéguen more than expected).

Fields of papers citing papers by G. Guéguen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Guéguen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Guéguen. The network helps show where G. Guéguen may publish in the future.

Co-authorship network of co-authors of G. Guéguen

This figure shows the co-authorship network connecting the top 25 collaborators of G. Guéguen. A scholar is included among the top collaborators of G. Guéguen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Guéguen. G. Guéguen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Blanc, Isabelle, Antoine Alam, Olivier Duclos, et al.. (2010). SAR131675, a new potent selective VEGFR-3-TK inhibitor: Effect on lymphangiogenic, tumor growth, and metastasis.. Journal of Clinical Oncology. 28(15_suppl). e13623–e13623. 1 indexed citations
2.
Fons, Pierre, Sophie Chabot, Judith E. Cartwright, et al.. (2006). Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood. 108(8). 2608–2615. 159 indexed citations
3.
Guéguen, G., V. Granci, Fabienne Briand‐Mésange, et al.. (2002). A lysophosphatidic acid analogue is revealed as a potent inhibitor of phosphatidylcholine synthesis, inducing apoptosis. Biochemical Journal. 368(2). 447–459. 9 indexed citations
4.
Guéguen, G., Jean‐Michel Grévy, J. Bellan, et al.. (1999). Structure−Activity Analysis of the Effects of Lysophosphatidic Acid on Platelet Aggregation. Biochemistry. 38(26). 8440–8450. 65 indexed citations
5.
Gaits‐Iacovoni, Frédérique, Olivier Fourcade, G. Guéguen, et al.. (1997). Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis. FEBS Letters. 410(1). 54–58. 148 indexed citations
6.
Michel, J., G. Guéguen, Joseph Vercauteren, & Serge Moreau. (1997). Triplex stability of oligodeoxynucleotides containing substituted quinazoline-2,4-(1H,3H)-dione. Tetrahedron. 53(25). 8457–8478. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026